DRUG Bright Minds Biosciences Inc.
$55.53▼ -2.05%
Healthcare
Other
Volume 27.6K
Avg Volume (10D) 102.9K
Key Metrics & Fundamentals
Market Cap
$547.75M
P/E Ratio
–
Div Yield
0.00%
52W Range
47.23 - 123.75
% vs 50 MA
-4.97%
% vs 200 MA
-22.81%
RSI-14
53.9
MACD Histogram
+1.0200
Beta (1Y vs SPY)
1.57
Free Cash Flow
-$8.34M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$17.66M
COGS
–
Operating Exp
$11.43M
Operating Income
-$11.43M
EBIT
-$11.43M
Pretax Income
-$2.40M
Net Income
-$2.40M
EPS (Diluted)
-0.24
Price & Volume History
Loading chart…
Recent News

Top 3 Canadian Biotech Stocks To Watch In October 2026
Simply Wall St. · Oct 29, 2026 1:10 PM ET

3 Canadian Biotech Stocks With Up To 39% Net Margins
Simply Wall St. · Oct 22, 2026 12:14 PM ET

3 Canadian Biotech Stocks Trading Up To 93% Below Fair Value
Simply Wall St. · Oct 15, 2026 6:10 AM ET

Bright Minds Biosciences And 2 More Canadian Biotech Stocks
Simply Wall St. · Oct 8, 2026 5:09 AM ET

Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
GlobeNewswire · Sep 30, 2026 5:30 PM ET

Auxly Cannabis Group And 2 Other Canadian Biotech Stocks To Watch
Simply Wall St. · Sep 30, 2026 4:11 PM ET

3 Small Cap Stocks With Strong Revenue Growth And Low Debt
Simply Wall St. · Sep 15, 2026 8:46 PM ET

Bright Minds Biosciences to Present at Upcoming Conferences
GlobeNewswire · Sep 4, 2026 4:30 PM ET

What Makes Bright Minds Biosciences Inc. (DRUG) a Strong Momentum Stock: Buy Now?
Zacks · Aug 27, 2026 12:00 PM ET

Wall Street Analysts See a 97.01% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?
Zacks · Aug 26, 2026 9:55 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DRUG's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.